A Medicare Advantage OTC Benefit Study

Thank you

This live web event has ended. Thank you for attending.

Description

Nearly 18 million seniors have access to a plan-funded and administered OTC benefit through their Medicare Advantage plans. The benefit includes many OTC medicines as well as a broad number of consumer medical devices and select dietary supplements.

Cary Badger and Zain Jafri will present the results of a first-of-its-kind study, with a deep dive into three question areas:

Webinar Objectives

What are the basics of the Medicare Advantage marketplace?
What are the findings from an analysis of one regional plan’s data on enrollees who used the OTC benefit versus those who did not?
What are the opportunities for plans to shift from seeing the OTC benefit as a member acquisition tool to integrating the benefit into both customer satisfaction and care management strategies? Just as important, how can product manufacturers engage with plans to help realize this potential?

CHPA’s David Spangler will moderate this webinar.

Contributors

Cary Badger

Cary Badger has over 25 years of healthcare industry experience with deep Medicare Advantage expertise, health plan operations, product development, marketing and sales, planning and business development. Cary assists HealthScape’s clients with market expansion and acquisition strategies, strategic partnerships, build/buy/outsourcing, new market and product entry and overall MA and commercial plan performance improvement.
Zain Jafri

Zain Jafri leads Pareto’s Innovation and Analytics team. He is responsible for building new analytics capabilities and pursuing innovation opportunities at Pareto. He also oversees the development and commercialization of emerging products, while keeping an ear to the market and our clients’ needs to identify new problems to solve or how new features (e.g., machine learning, artificial intelligence) can enhance our current solutions.
David Spangler

David Spangler leads the association’s team of eight across legal, government affairs, and policy functions. He has particular expertise in regulatory matters.

Spangler joined CHPA in 1984 as a legislative analyst. He subsequently served in a number of roles for the association in the president's office, project management, international affairs, and, after completing law school in 1995, the association's legal department. Spangler was named a vice president in 1997, and a senior vice president in 2006. His responsibilities were expanded to his current role in 2019.

Spangler is a member of the District of Columbia Bar as well as the American Society of Association Executives. He authored the chapter on OTC medicines in "Modern Pharmaceutical Industry: A Primer" (Jacobsen and Wertheimer, eds., 2009) and has served on a range of committees and working groups for the Food and Drug Law Institute and the Global Self-Care Federation. Spangler earned his Certificate in Organizational Management in 1991 from the U.S. Chamber of Commerce's Institute for Organization Management.